Pires Cristiana L, Moreno Maria João
Coimbra Chemistry Center-Institute of Molecular Sciences (CQC-IMS), University of Coimbra, 3004-535 Coimbra, Portugal.
Chemistry Department, Faculty of Science and Technology, University of Coimbra, 3004-535 Coimbra, Portugal.
Membranes (Basel). 2024 Jul 14;14(7):157. doi: 10.3390/membranes14070157.
The ability to predict the rate of permeation of new compounds across biological membranes is of high importance for their success as drugs, as it determines their efficacy, pharmacokinetics, and safety profile. In vitro permeability assays using Caco-2 monolayers are commonly employed to assess permeability across the intestinal epithelium, with an extensive number of apparent permeability coefficient () values available in the literature and a significant fraction collected in databases. The compilation of these values for large datasets allows for the application of artificial intelligence tools for establishing quantitative structure-permeability relationships (QSPRs) to predict the permeability of new compounds from their structural properties. One of the main challenges that hinders the development of accurate predictions is the existence of multiple values for the same compound, mostly caused by differences in the experimental protocols employed. This review addresses the magnitude of the variability within and between laboratories to interpret its impact on QSPR modelling, systematically and quantitatively assessing the most common sources of variability. This review emphasizes the importance of compiling consistent data and suggests strategies that may be used to obtain such data, contributing to the establishment of robust QSPRs with enhanced predictive power.
预测新化合物跨生物膜渗透速率的能力对于其作为药物的成功至关重要,因为这决定了它们的疗效、药代动力学和安全性。使用Caco-2单层细胞的体外渗透性测定通常用于评估跨肠上皮的渗透性,文献中有大量的表观渗透系数()值,并且有相当一部分收集在数据库中。为大型数据集汇编这些值允许应用人工智能工具来建立定量结构-渗透关系(QSPR),以根据新化合物的结构特性预测其渗透性。阻碍准确预测发展的主要挑战之一是同一化合物存在多个值,这主要是由所采用的实验方案的差异引起的。本综述探讨了实验室内部和实验室之间变异性的程度,以解释其对QSPR建模的影响,系统地和定量地评估最常见的变异性来源。本综述强调了汇编一致数据的重要性,并提出了可用于获取此类数据的策略,有助于建立具有增强预测能力的稳健QSPR。
Eur J Pharm Biopharm. 2017-5
Mol Pharm. 2023-7-3
Pharmaceutics. 2023-1-12